np event 2254995 0E193A 1
Jul 30, 2024
- Jul 29, 2025
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
1.0

Claim your credit

Already have an Account? Log In
Don’t have an account? Register Today

 Claim your Certificate

Related Courses

np document 888746 0E193A 5
Pulmonology
Clinical Update for Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations...
np document 888746 0E193A 5
Rheumatology
Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Eryth...
np microphone 888718 0E193A 1
Pulmonology
Therapeutic Update on COPD with Type 2 Inflammation